Opioids Market

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Type Innovation / Development Trends

4. Key Success Factors

    4.1. Adoption Rate/Usage Analysis- Key Statistics

    4.2. Key Regulations, By Region

    4.3. PEST Analysis

    4.4. Commercial Scope

    4.5. Reimbursement Landscape

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising prevalence of chronic diseases and trauma conditions

        5.2.2. Unavailability of opioids in Asian and African countries

        5.2.3. Increasing product approval

        5.2.4. Increasing commercialisation of novel products

        5.2.5. Merger & Acquisitions

        5.2.6. Regulatory Policies

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue by Product

        6.4.2. Revenue by Application

        6.4.3. Revenue by End User

        6.4.4. Revenue by Country

    6.5. 2020 Market Scenario

    6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2020

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2021-2031

        8.3.1. Morphine

        8.3.2. Codeine

        8.3.3. Fentanyl

        8.3.4. Meperidine

        8.3.5. Methadone

    8.4.  Market Attractiveness Analysis by Product  

9. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Application

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031

        9.3.1. Analgesics

        9.3.2. Cough Suppression

        9.3.3. Diarrhea Suppression

    9.4.  Market Attractiveness Analysis by Application  

10. Market Attractiveness Analysis by Type  Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Diagnostic Imaging Centers

        10.3.4. Specialty Clinics

        10.3.5. Cancer Research Institutes

    10.4.  Market Attractiveness Analysis by Distribution Channel 

11. Global Opioids Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis by Region, 2016- 2020

    11.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021- 2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis by Region

12. North America Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    12.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. Latin America Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2015 - 2019

    13.3. Market Size (US$ Mn) Analysis Forecast by Market Taxonomy, 2021-2031

        13.3.1. By Country

            13.3.1.1. Brazil

            13.3.1.2. Mexico

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Europe Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    14.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. South Asia Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    15.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Thailand

            15.3.1.3. Indonesia

            15.3.1.4. Malaysia

            15.3.1.5. Rest of South Asia

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. East Asia Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    16.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By Application

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. Oceania Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    17.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    18.3. Current Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. Rest of Middle East and Africa

        18.3.2. By Product

        18.3.3. By Application

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Key and Emerging Countries Opioids Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Global Vs. Country Growth Comparison

    19.2. U.S. Opioids Market  Value (US$) Analysis, 2020 & 2031

        19.2.1. By Product

        19.2.2. By Application

        19.2.3. By Distribution Channel

    19.3. Canada Opioids Market Value (US$) Analysis, 2020 & 2031

        19.3.1. By Product

        19.3.2. By Application

        19.3.3. By Distribution Channel

    19.4. Brazil Opioids Market Value (US$) Analysis, 2020 & 2031

        19.4.1. By Product

        19.4.2. By Application

        19.4.3. By Distribution Channel

    19.5. Mexico Opioids Market Value (US$) Analysis, 2020 & 2031

        19.5.1. By Product

        19.5.2. By Application

        19.5.3. By Distribution Channel

    19.6. Argentina Opioids Market Value (US$) Analysis, 2020 & 2031

        19.6.1. By Product

        19.6.2. By Application

        19.6.3. By Distribution Channel

    19.7. Germany Opioids Market Value (US$) Analysis, 2020 & 2031

        19.7.1. By Product

        19.7.2. By Application

        19.7.3. By Distribution Channel

    19.8. France Opioids Market Value (US$) Analysis, 2020 & 2031

        19.8.1. By Product

        19.8.2. By Application

        19.8.3. By Distribution Channel

    19.9. U.K. Opioids Market Value (US$) Analysis, 2020 & 2031

        19.9.1. By Product

        19.9.2. By Application

        19.9.3. By Distribution Channel

    19.10. Spain Opioids Market Value (US$) Analysis, 2020 & 2031

        19.10.1. By Product

        19.10.2. By Application

        19.10.3. By Distribution Channel

    19.11. BENELUX Opioids Market Value (US$) Analysis, 2020 & 2031

        19.11.1. By Product

        19.11.2. By Application

        19.11.3. By Distribution Channel

    19.12. Russia Opioids Market Value (US$) Analysis, 2020 & 2031

        19.12.1. By Product

        19.12.2. By Application

        19.12.3. By Distribution Channel

    19.13. India Opioids Market Value (US$) Analysis, 2020 & 2031

        19.13.1. By Product

        19.13.2. By Application

        19.13.3. By Distribution Channel

    19.14. Thailand Opioids Market Value (US$) Analysis, 2020 & 2031

        19.14.1. By Product

        19.14.2. By Application

        19.14.3. By Distribution Channel

    19.15. Indonesia Opioids Market Value (US$) Analysis, 2020 & 2031

        19.15.1. By Product

        19.15.2. By Application

        19.15.3. By Distribution Channel

    19.16. Malaysia Opioids Market Value (US$) Analysis, 2020 & 2031

        19.16.1. By Product

        19.16.2. By Application

        19.16.3. By Distribution Channel

    19.17. China Opioids Market Value (US$) Analysis, 2020 & 2031

        19.17.1. By Product

        19.17.2. By Application

        19.17.3. By Distribution Channel

    19.18. Japan Opioids Market Value (US$) Analysis, 2020 & 2031

        19.18.1. By Product

        19.18.2. By Application

        19.18.3. By Distribution Channel

    19.19. South Korea Opioids Market Value (US$) Analysis, 2020 & 2031

        19.19.1. By Product

        19.19.2. By Application

        19.19.3. By Distribution Channel

    19.20. Australia Opioids Market Value (US$) Analysis, 2020 & 2031

        19.20.1. By Product

        19.20.2. By Application

        19.20.3. By Distribution Channel

    19.21. New Zealand Opioids Market Value (US$) Analysis, 2020 & 2031

        19.21.1. By Product

        19.21.2. By Application

        19.21.3. By Distribution Channel

    19.22. GCC Countries Opioids Market Value (US$) Analysis, 2020 & 2031

        19.22.1. By Product

        19.22.2. By Application

        19.22.3. By Distribution Channel

    19.23. Italy  Opioids Market Value (US$) Analysis, 2020 & 2031

        19.23.1. By Product

        19.23.2. By Application

        19.23.3. By Distribution Channel

    19.24. South Africa Opioids Market Value (US$) Analysis, 2020 & 2031

        19.24.1. By Product

        19.24.2. By Application

        19.24.3. By Distribution Channel

    19.25. Turkey Opioids Market Value (US$) Analysis, 2020 & 2031

        19.25.1. By Product

        19.25.2. By Application

        19.25.3. By Distribution Channel

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies 

    20.2. Market Share Analysis of Top Players

    20.3. Market Concentration

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Deep Dive 

        21.2.1. Pfizer, Inc.

            21.2.1.1. Overview

            21.2.1.2. Product Portfolio

            21.2.1.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.1.4. Sales Footprint

            21.2.1.5. Strategy Overview

        21.2.2. Boehringer Ingelheim International GmbH

            21.2.2.1. Overview

            21.2.2.2. Product Portfolio

            21.2.2.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.2.4. Sales Footprint

            21.2.2.5. Strategy Overview

        21.2.3. Janssen Pharmaceuticals, Inc.

            21.2.3.1. Overview

            21.2.3.2. Product Portfolio

            21.2.3.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.3.4. Sales Footprint

            21.2.3.5. Strategy Overview

        21.2.4. Sanofi SAIS

            21.2.4.1. Overview

            21.2.4.2. Product Portfolio

            21.2.4.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.4.4. Sales Footprint

            21.2.4.5. Strategy Overview

        21.2.5. Sun Pharmaceutical Industries Ltd.

            21.2.5.1. Overview

            21.2.5.2. Product Portfolio

            21.2.5.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.5.4. Sales Footprint

            21.2.5.5. Strategy Overview

        21.2.6. Actavis Plc. [Teva Pharmaceutical Industries Ltd.]

            21.2.6.1. Overview

            21.2.6.2. Product Portfolio

            21.2.6.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.6.4. Sales Footprint

            21.2.6.5. Strategy Overview

        21.2.7. Mallinckrodt Pharmaceuticals

            21.2.7.1. Overview

            21.2.7.2. Product Portfolio

            21.2.7.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.7.4. Sales Footprint

            21.2.7.5. Strategy Overview

        21.2.8. Endo Pharmaceuticals Inc. [Endo International plc]

            21.2.8.1. Overview

            21.2.8.2. Product Portfolio

            21.2.8.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.8.4. Sales Footprint

            21.2.8.5. Strategy Overview

        21.2.9. Purdue Pharma L.P.

            21.2.9.1. Overview

            21.2.9.2. Product Portfolio

            21.2.9.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.9.4. Sales Footprint

            21.2.9.5. Strategy Overview

        21.2.10. Assertio Therapeutics, Inc. [Assertio Holdings, Inc.]

            21.2.10.1. Overview

            21.2.10.2. Product Portfolio

            21.2.10.3. Profitability by Market Segments (Product/Channel/Region)

            21.2.10.4. Sales Footprint

            21.2.10.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

Table 01: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 02: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 03: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 04: Global Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region

Table 05: North America Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 06: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 07: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 08: North America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 09: Latin America Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 10: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 11: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 12: Latin America Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 13: Europe Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 14: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 15: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 16: Europe Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 17: South Asia Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 18: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 19: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 20: South Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 21: East Asia Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 22: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 23: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application

Table 24: East Asia Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 25: Oceania Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 26: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 27: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application 

Table 28: Oceania Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

Table 29: Middle East and Africa Opioids Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 30: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product 

Table 31: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Application 

Table 32: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Product

Table 33: Middle East and Africa Opioids Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel

List of Chart

Figure 01: Global Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 02: Global Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 03: Global Opioids Market Absolute $ Opportunity, 2021 - 2031

Figure 04: Global Opioids Market Share Analysis (%), By Product, 2021-2031

Figure 05: Global Opioids Market Y-o-Y Analysis (%), By Product, 2021-2031

Figure 06: Global Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 07: Global Opioids Market Share Analysis (%), By Application, 2021-2031

Figure 08: Global Opioids Market Y-o-Y Analysis (%), By Application, 2021-2031

Figure 09: Global Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 10: Global Opioids Market Share Analysis (%), By Distribution Channel, 2021-2031

Figure 11: Global Opioids Market Y-o-Y Analysis (%), By Distribution Channel, 2021-2031

Figure 12: Global Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 13: Global Opioids Market Share Analysis (%), By Region, 2021-2031

Figure 14: Global Opioids Market Y-o-Y Analysis (%), By Region, 2021-2031

Figure 15: Global Opioids Market Attractiveness Analysis by Region, 2021-2031

Figure 16: North America Opioids Market Value Share, By Product, 2021 (E)

Figure 17: North America Opioids Market Value Share, By Application, 2021 (E)

Figure 18: North America Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 19: North America Opioids Market Value Share, By Country, 2021 (E)

Figure 20: North America Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 21: North America Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 22: North America Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 23: North America Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 24: North America Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 25: North America Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 26: Latin America Opioids Market Value Share, By Product, 2021 (E)

Figure 27: Latin America Opioids Market Value Share, By Application, 2021 (E)

Figure 28: Latin America Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 29: Latin America Opioids Market Value Share, By Country, 2021 (E)

Figure 30: Latin America Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 31: Latin America Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 32: Latin America Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 33: Latin America Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 34: Latin America Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 35: Latin America Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 36: Europe Opioids Market Value Share, By Product, 2021 (E)

Figure 37: Europe Opioids Market Value Share, By Application, 2021 (E)

Figure 38: Europe Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 39: Europe Opioids Market Value Share, By Country, 2021 (E)

Figure 40: Europe Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 41: Europe Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 42: Europe Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 43: Europe Opioids Market Attractiveness Analysis, By Application 2021-2031

Figure 44: Europe Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 45: Europe Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 46: South Asia Opioids Market Value Share, By Product, 2021 (E)

Figure 47: South Asia Opioids Market Value Share, By Application, 2021 (E)

Figure 48: South Asia Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 49: South Asia Opioids Market Value Share, By Country, 2021 (E)

Figure 50: South Asia Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 51: South Asia Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 52: South Asia Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 53: South Asia Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 54: South Asia Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 55: South Asia Opioids Market Attractiveness Analysis, By Country, 2021-2031

Figure 56: East Asia Opioids Market Value Share, By Product, 2021 (E)

Figure 57: East Asia Opioids Market Value Share, By Application, 2021 (E)

Figure 58: East Asia Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 59: East Asia Opioids Market Value Share, By Country, 2021 (E)

Figure 60: East Asia Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 61: East Asia Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 62: East Asia Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 63: East Asia Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 64: East Asia Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 65: East Asia Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 66: Oceania Opioids Market Value Share, By Product, 2021 (E)

Figure 67: Oceania Opioids Market Value Share, By Application, 2021 (E)

Figure 68: Oceania Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 69: Oceania Opioids Market Value Share, By Country, 2021 (E)

Figure 70: Oceania Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 71: Oceania Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 72: Oceania Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 73: Oceania Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 74: Oceania Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 75: Oceania Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 76: Middle East and Africa Opioids Market Value Share, By Product, 2021 (E)

Figure 77: Middle East and Africa Opioids Market Value Share, By Application, 2021 (E)

Figure 78: Middle East and Africa Opioids Market Value Share, By Distribution Channel, 2021 (E)

Figure 79: Middle East and Africa Opioids Market Value Share, By Country, 2021 (E)

Figure 80: Middle East and Africa Opioids Market Value Analysis (US$ Mn), 2016-2020

Figure 81: Middle East and Africa Opioids Market Value Forecast (US$ Mn), 2021-2031

Figure 82: Middle East and Africa Opioids Market Attractiveness Analysis, By Product, 2021-2031

Figure 83: Middle East and Africa Opioids Market Attractiveness Analysis, By Application, 2021-2031

Figure 84: Middle East and Africa Opioids Market Attractiveness Analysis, By Distribution Channel, 2021-2031

Figure 85: MEA Opioids Market Attractiveness Analysis by Country, 2021-2031

Figure 86: Global Opioids Market Value Proportion Analysis, By Countries, 2021 (E)

Figure 87: Opioids Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2021-2031

Figure 88: U.S Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 89: U.S Opioids Market Share Analysis (%), Application, 2020 & 2031

Figure 90: U.S Opioids Market Share Analysis (%), By Distribution Channel, 2020 & 2031

Figure 91: Global Vs. U.S Growth Comparison

Figure 92: Canada Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 93: Canada Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 94: Canada Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 95: Global Vs. Canada Growth Comparison

Figure 96: Brazil Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 97: Brazil Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 98: Brazil Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 99: Global Vs. Brazil Growth Comparison

Figure 100: Mexico Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 101: Mexico Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 102: Mexico Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 103: Global Vs. Mexico Growth Comparison

Figure 104: Argentina Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 105: Argentina Opioids Market Share Analysis (%), Application, 2020 & 2031

Figure 106: Argentina Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 107: Global Vs. Argentina Growth Comparison

Figure 108: Germany Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 109: Germany Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 110: Germany Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 111: Global Vs. Germany Growth Comparison

Figure 112: France Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 113: France Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 114: France Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 115: Global Vs. France Growth Comparison

Figure 116: U.K Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 117: U.K Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 118: U.K Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 119: Global Vs. U.K Growth Comparison

Figure 120: Spain Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 121: Spain Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 122: Spain Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 123: Global Vs. Spain Growth Comparison

Figure 124: BENELUX Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 125: BENELUX Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 126: BENELUX Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 127: Global Vs. BENELUX Growth Comparison

Figure 128: Russia Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 129: Russia Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 130: Russia Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 131: Global Vs. Russia Growth Comparison

Figure 132: India Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 133: India Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 134: India Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 135: Global Vs. India Growth Comparison

Figure 136: Thailand Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 137: Thailand Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 138: Thailand Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 139: Global Vs. Thailand Growth Comparison

Figure 140: Indonesia Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 141: Indonesia Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 142: Indonesia Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 143: Global Vs. Indonesia Growth Comparison

Figure 144: Malaysia Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 145: Malaysia Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 146: Malaysia Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 147: Global Vs. Malaysia Growth Comparison

Figure 148: China Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 149: China Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 150: China Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 151: Global Vs. China Growth Comparison

Figure 152: Japan Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 153: Japan Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 154: Japan Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 155: Global Vs. Japan Growth Comparison

Figure 156: South Korea Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 157: South Korea Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 158: South Korea Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 159: Global Vs. South Korea Growth Comparison

Figure 160: Australia Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 161: Australia Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 162: Australia Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 163: Global Vs. Australia Growth Comparison

Figure 164: New Zealand Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 165: New Zealand Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 166: New Zealand Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 167: Global Vs. New Zealand Growth Comparison

Figure 168: GCC Countries Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 169: GCC Countries Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 170: GCC Countries Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 171: Global Vs. GCC Countries Growth Comparison

Figure 172: Italy Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 173: Italy Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 174: Italy Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 175: Global Vs. Italy Growth Comparison

Figure 176: South Africa Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 177: South Africa Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 178: South Africa Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 179: Global Vs. South Africa Growth Comparison

Figure 180: Turkey Opioids Market Share Analysis (%), By Product, 2020 & 2031

Figure 181: Turkey Opioids Market Share Analysis (%), By Application, 2020 & 2031

Figure 182: Turkey Opioids Market Share Analysis (%), By Distribution Channel, 2020 &2030

Figure 183: Global Vs. Turkey Growth Comparison

Description

Global Opioids Market- Scope of Report

A latest publication by Persistence Market Research on the global opioids market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on key market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for successful growth of the opioids market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described in an exhaustive way in Persistence Market Research's study. This research study can support readers to know the demand for opioids and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the opioids landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the market. Insights and wisdom presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the opioids market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the opioids industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the opioids market offers information divided into four important segments — product, application, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Key Questions Answered in Report

• Which geographic regions will continue to remain the most profitable markets for opioids over the coming years?
• How will changing trends impact the opioids market?
• How has the COVID-19 crisis impacted market growth?
• How can market players capture the low-hanging opportunities in developed regions?
• What are the strategies of stakeholders in the opioids market to shape their position in this landscape?
• What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
• What are the developmental trends that will impact the market?
• How can businesses in the opioids market avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the opioids market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of opioids market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the opioids market more accurate and reliable.